Corporate Website
Africa
Argentina
Asia
Australia
Belgium
Brazil
Bulgaria
Canada (EN)
Chile
China
Colombia
Denmark
Egypt
France
Germany
Greece
Hungary
Indonesia
Italia
India
Japan
Korea
Malaysia
Mexico
Middle East
Netherlands
Peru
Philippines
Poland
Portugal
Romania
Russia
South Africa
Spain
Sweden
Thailand
Tunisia
Turkey
Ukraine
United Kingdom
USA
Vietnam
Your search for "Sogeval acquisition" return 17 results.
CEVA EXPANDS ORAL RABIES VACCINE PORTFOLIO WITH THE ACQUISITION OF CANADIAN FIRM ARTEMIS TECHNOLOGIES, INC. >
Libourne, May 16, 2022 – Ceva Santé Animale (Ceva) has acquired the Canadian oral rabies vaccine manufacturer Artemis Technologies, Inc. Artemis, located in Guelph, ON, Canada, produces ONRAB®, a ra...
Ceva Returns Strong Double-Digit Growth in 2019; Plans to Double sales by 2020. >
Consolidated sales of the Ceva Group reached more than €1.2 billion in 2019.
Ceva Santé Animale confirms its circle of virtuous growth in 2016 >
2016 was a year of sustained organic growth and major acquisitions. Consolidated sales reached €912m.
Ceva Animal Health posts strong double-digit growth again in 2014 >
Sales grew in all zones and across all species
Ceva Animal Health completes integration of Sogeval Animal Health >
Ceva Animal Health’s integration of Sogeval Laboratories is strengthening the company’s ability to provide total pet health solutions to veterinarians and their clients.
Sogeval to rename Tri-Cox; now TRP-Tri-COX >
In connection with a trademark infringement lawsuit brought by PSPC, Inc. against Sogeval Laboratories, Inc. in the United State District Court for the Middle District of Florida, the parties have ent...
Ceva Animal Health Acquires Sogeval >
Ceva Animal Health has acquired Sogeval, a subsidiary of Sofiprotéol, solidifying Ceva’s position as a Top 10 global animal health company.
Ceva in exclusive merger negotiations with Sogeval >
French veterinary pharmaceutical companies Ceva Santé Animale (Ceva), based in Libourne, and Sogeval (a subsidiary of Sofiprotéol), based in Laval have entered into exclusive merger negotiations.
Ceva Animal Health Introduces Vectormune® HVT-LT >
Vector vaccine protects agains both Infectious Laryngotracheitis and Marek's disease
Ceva Animal Health Set For Continued Growth In 2012 >
Update on Ceva's growth in North America